Transdermal Hormone Replacement Therapy for Menopausal Skin & Allergy Relief

🌸 Hormones & Skin in Midlife: Why Menopause Hits You Hard 🌸

Doc, I was fine until I hit my 50s

Then I started developing allergies,

My skin is so sensitive, I sometimes have mood changes.

Do you think menopause is the issue? I was so happy not getting periods.

Now I’m not so sure!

If you’re in your 50s or 60s and suddenly battling itchy patches, hives, or eczema — you are not alone.

As estrogen levels fall, your skin’s natural defenses weaken, leaving you prone to flares you never saw coming.

Why Menopause Makes Your Skin Sensitive

Estrogen’s Superpowers:

  • Boosts collagen & natural oils

  • Keeps skin plump, hydrated, and resilient

  • Calms inflammation

When Estrogen Drops:

  • Skin thins, dries, and cracks

  • Eczema and urticaria can flare explosively

  • Even rosacea or contact dermatitis worsen

The Rise, Fall & Comeback of HRT

1990s Hype

  • Doctors prescribed hormones to prevent heart disease, osteoporosis, dementia—based on observational data.

2002 WHI Shock

  • Combined oral HRT (estrogen + progestin) showed small upticks in heart attacks, strokes, breast cancer, and clots in older women.

Nuanced Risks

  • Absolute extra events: ~7 heart attacks, 8 strokes, 8 breast cancers, 18 clots per 10,000 women/year.

  • Benefits for hot flashes, night sweats, and skin flares remained clear.

Today’s Take

  • Symptom-driven, long-term therapy: Continue transdermal estrogen (with progesterone if you have a uterus) for as long as your menopausal symptoms persist—often 5–10+ years, tailored to your risk profile.

  • Why Transdermal?

    • Lower, steadier dosing: No peaks & valleys of oral pills.

    • Liver-friendly: Bypasses first-pass metabolism, so clotting factors and lipid changes stay minimal.

    • Safety: A large Swedish BMJ study of 900,000 women showed no increase in heart attack, stroke, composite CVD, or VTE—and even hinted at a slight reduction in MI and overall CVD

Comparing Transdermal vs. Oral Estrogen

How We’re Different: Transdermal + Progesterone

At our clinic, we partner with a Compounding Pharmacy for a customized transdermal cream combining:

  • Bioidentical Estradiol: Replenishes what menopause steals away.

  • Micronized Progesterone: Balances estrogen, protects your uterus, and adds its own skin-friendly perks.

Progesterone Perks:

  • Soothes sensitive skin and calms inflammation

  • Promotes sleep by enhancing GABA activity, which indirectly supports skin healing

Beyond Hot Flashes: Extra Benefits You’ll Feel

  • Mood Lifter: Estrogen boosts serotonin and endorphins—easing anxiety, low mood, and brain-fog .

  • UTI Defense: Topical vaginal estrogen restores the urinary and vaginal lining—cutting recurrent UTI risk by up to 50% in postmenopausal women .

  • Stronger Barrier: Improved hydration and lipid production mean fewer eczema and hives flares.

Why Choose the Allergy Immunology Clinic?

✔️ Holistic Assessment: We evaluate your skin, mood, sleep, and heart-health risk.
✔️ Custom Compounded Creams: Partnered with a leading compounding pharmacy for precise dosing.
✔️ Transdermal First: Creams to minimize systemic side effects.
✔️ Allergy & Skin Expertise: We treat eczema and urticaria alongside menopausal symptoms.
✔️ Ongoing Monitoring: Symptom tracking, lab checks, and tailored adjustments.

Ready for Relief?

Don’t let menopausal skin woes—and mood swings—define your midlife. Transdermal HRT with progesterone can restore your skin barrier, calm flares, and even boost your mood and urinary health—all under expert supervision.

📌 Book your consultation today and discover personalized hormone-and-skin solutions that truly work.

References

Hall G, Phillips TJ. Estrogen and skin: the effects of estrogen, menopause, and hormone replacement therapy on the skin. J Am Acad Dermatol. 2005 Oct;53(4):555-68; quiz 569-72.

Mohammed K, Abu Dabrh AM, Benkhadra K, Al Nofal A, Carranza Leon BG, Prokop LJ, Montori VM, Faubion SS, Murad MH. Oral vs Transdermal Estrogen Therapy and Vascular Events: A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab. 2015 Nov;100(11):4012-20.

Bravo, B.; Penedo, L.; Carvalho, R.; Dal Vesco, C.; Calomeni, M.; Gapanowicz, D.; Kemen, E.; Paes, R.; Renke, G. Dermatological Changes during Menopause and HRT: What to Expect? Cosmetics 2024, 11, 9.

Johansson T, Karlsson T, Bliuc D, Schmitz D, Ek WE, Skalkidou A, Center JR, Johansson Å. Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial. BMJ. 2024 Nov 27;387:e078784.

Recent Posts: